Search Results for "liquid biopsy"
Model suggests liquid biopsy improves prostate cancer outcomes, but that’s not the real world
The release would have been more complete with a discussion on cost, harms and a better description of the evidence.
"Liquid biopsy" test improves health outcomes and can save over $500 million annually for the U.S. healthcare system
Readers drowning in flawed “liquid biopsy” stories; other coverage throws a lifeline
The big story out of the American Society of Clinical Oncology meeting over the weekend came from a study about so-called “liquid biopsies.” Major news organizations headlined it as follows: Washington Post: ‘Liquid biopsy’ study offers hope for a blood test to find cancer New York Times: ‘Liquid’ Cancer Test Offers Hope for Alternative to […]
Bloomberg “liquid biopsy” story nods to “skepticism” in headline
We liked the headline on this story and it features some good restraining comments, but it fell short on discussion of harms and alternatives.
Consumer Blood Test to Detect Cancer Hits Market Amid Skepticism
Reuters adds some cold water to direct-to-consumer ‘liquid biopsy’
This story wasn’t dazzled by the novelty of a liquid biopsy and provided enough cautionary notes, more so than a competing Bloomberg story.
Pathway launches 'liquid biopsy' to find cancer in healthy people
5-Star Friday: liquid biopsies, resveratrol, Med diet and more
This is just a quick Friday shout out to a handful of recent 5-star efforts that we’ve reviewed and which deserve recognition: Reuters adds some cold water to direct-to-consumer ‘liquid biopsy’. Our reviewers called this one particularly strong on characterization of harms and pointed to this informative text: “Patients might be attracted to a less-invasive test […]
Problematic PR releases: Costs are hidden in cancer testing news
Precision medicine and the tests that enable it are becoming increasingly common in cancer care. So it’s no surprise that we see more and more PR announcements relating to cancer testing from a variety of institutions including government, academia, and industry. There’s little debate that some of these tests would benefit patients. But we also […]
Announcement oversells blood test for predicting treatment outcomes in prostate cancer
Some discussion of the cost, potential harms and study limitations surrounding this test would have made the release more useful for readers.
Blood Test Predicts Treatment Response and Survival for Patients with Metastatic Prostate Cancer
Numerous problems plague Guardian’s coverage of ‘holy grail of cancer research’
The Guardian story not only misleads readers with a grandiose headline, it fails to provide readers with a balanced discussion of the significant limitations and harms that many experts consider salient when it comes to liquid biopsies.
'Holy grail of cancer research': doctors positive about early detection blood test
For story on experimental prostate cancer blood test, Guardian leans heavily on news release
Unfortunately, this article glosses over the measured benefits, the costs, the harms–and much more.
Prostate cancer blood test could transform treatment, say scientists
WSJ story on prostate cancer treatment test leaves us wondering: Why no independent viewpoints?
A nod to conflicts of interest and the inclusion of independent experts would have provided crucial balance to a story dominated by commercial concerns.
Test Aids Prostate Cancer Treatment
AAAS stories hype immunotherapy, cancer saliva test
“Excitement” “Unprecedented” “Revolutionary” “Spectacular” “Dramatic” “Amazing” “Very large tumors simply melt away” All of these words were used in news stories to describe immunotherapy research results presented at the big annual meeting of the American Association for the Advancement of Science (AAAS) in Washington, DC. Results, that, according to the BBC, have also “not been […]1
Hypewatch: Journalists need to pour some cold water into that “Grail”
Imagine how wonderful it would be if a test from a single blood drawing could tell you whether you had evidence of cancer long before symptoms appeared and presumably early enough for effective treatment. Wonder no more, suggests a report from Bloomberg News. Illumina, a genetic sequencing company, has formed a new company — somewhat […]2
A final HealthNewsReview.org report card from 3,200+ systematic reviews of health care news stories & PR releases
In 2005, as I began building HealthNewsReview.org, I got permission from Dr. David Henry of the Media Doctor Australia project to adopt their news story review criteria. In the ensuing 13 years, no one has ever placed in front of me a solid, specific suggestion for a better set of criteria for reviewing stories about […]4 7/30/2018
Problematic PR releases: Where’s the data?
We’ve been closely tracking healthcare-related news releases for several years now, systematically reviewing more than 550 using our 10 criteria. We can’t get to every news release we see–the churn is vast. That’s why we’re starting a new ongoing blog series, problematic PR releases, looking at some of the big-picture problems we see in news […]
Plug for patent on ‘cancer trap’ device misleads
Based on the information in the release, the device appears to be — at this point — little more than a concept.